Year-end Sale % OFF 
Abstract
In December 2019, a novel severe acute respiratory syndrome coronavirus (SARS-Cov2) emerged in Wuhan, China, which is followed by the global pandemic of coronavirus disease (COVID-19). So far, COVID-19 is affecting the health and lives of millions of people and impacting the economy dramatically in more than 180 countries worldwide. Since the outbreak of COVID-19, potential medical treatments and vaccines have been developed and tested by biotech and pharmaceutical companies. Nutrition is critical for the prevention and recovery of diseases. Multiple nutrients have been considered as potential means to help in the combat against COVID-19. In addition, nutritional considerations are also important for people to maintain health when their daily dietary behaviors and physical activities are altered by COVID-19. Here, we tried to summarize potential medical treatments, vaccines, and important nutrients affecting outcomes of COVID-19 patients. In addition, we discussed the influences of dietary supplements and lifestyles for healthy and sensitive populations during the pandemic.
Highlights
As of 27 July, 2020, the World Health Organization reported that the number of people with Coronavirus Disease 2019 (COVID-19), a disease due to infection of severe acute respiratory syndrome coronavirus 2 (SARSCoV2) has reached 16,114,449, and caused 646,641 deaths [1]
The results show that unhealthy lifestyle similar to noncommunicable disease which is a risk factor for COVID-19
Data of dietary intake collected from 820 adolescents between 10-19 years old residing in Spain, Italy, Brazil, Colombia, and Chile show that confinement during COVID-19 pandemic influences their dietary behaviors [70]
Summary
As of 27 July, 2020, the World Health Organization reported that the number of people with Coronavirus Disease 2019 (COVID-19), a disease due to infection of severe acute respiratory syndrome coronavirus 2 (SARSCoV2) has reached 16,114,449, and caused 646,641 deaths (https://covid19.who.int/) [1]. In an uncontrolled study that includes 5 severe cases of COVID-19 supported with mechanical ventilation, the clinical symptoms of those cases improved after they received convalescent plasma 10-22 days after hospitalization [24]. This success leads the medical researchers to consider the potential and possibilities of collecting plasma of COVID‐19 convalescent patients to prevent the deterioration of infected COVID-19 cases in the early stage [24]. Double-blind, placebo-controlled, multicenter trial study in Wuhan, China, remdesivir shows no significant effect on the treatment of COVID19. The most recent one started on June 18, 2020 and is developed by Curevac in Germany
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
